baber/WOPTO huggingface dataset:
Patent CN-100535469-C (CN)
Title: 车用环形制动器
Inventor: YONG ZHANG
IPC: F16D65/18
Filed: 2007-07-05
Granted: 2009-09-02
Abstract: 本发明涉及一种汽车制动装置。一种车用环形制动器，包括有制动底板(3)、摩擦片(2)，其特征是在制动底板(3)上固连有数个活塞油缸组件(5)，在活塞油缸组件(5)内设有密封弹簧组件(8)，密封弹簧组件(8)的伸缩杆(81)外端固连摩擦片(2)；活塞油缸组件(5)通过油管连接螺母(15)与密封的环形油管(14)将活塞油缸组件(5)两两相连接；在制动底板(3)和摩擦片(2)上还设有回位弹簧(18)。本发明能防止制动鼓的抱死，使汽车制动能力增强，制动时汽车不跑偏、不侧滑，并减少了制动距离，提高了汽车制动安全性。
Patent CN-100562985-C (CN)
Inventor: LAN LUNG HSIANG
IPC: H01L21/82
Filed: 2007-12-05
Granted: 2009-11-25
Abstract: 本发明公开一种用以在制造存储单元时在电介质材料中生成自对准空洞的方法。先形成基底层，其包括导电元件。接着在所述基底层上再形成上层，所述上层形成步骤包括在所述基底层上形成第三、平坦化停止层、在所述第三层上形成第二层以及在所述第二层上形成第一层。然后形成微孔开口穿透所述上层以暴露所述导电元件的表面。此第一层具有凸悬部分延伸进入所述开口，使得所述第一宽度小于所述第二宽度。最后沉积所述电介质材料在所述开口部分，以在所述微孔开口中生成自对准的空洞。在某些实施例中，此微孔形成步骤包含增加所述第一层的体积，而在其他的实施例中，此微孔形成步骤包含将所述第二层回蚀刻。
Patent CA-1336923-E (CA)
Inventor: SCHLOENDORFF GEORG
IPC: A61B90/00
Filed: 1995-01-10
Granted: 1995-09-05
Abstract: A method and apparatus are described for the reproducible representation of a surgical procedure. The position or path of movement of the surgical instrument during the operation on concealed parts of the body is represented in order to document the course and results of a surgical procedure and then stored for subsequent examination. This is achieved in that a stratified image that has at least three measurement points on the patient is stored in a computer and reproduced on a display. In addition, the position of the three measurement points and the position of the surgical instrument can be determined before and during the procedure through a coordinate measurement system, superimposed with the stratified image on the display, and stored in a memory unit. The method and the apparatus (coordinate-measurement system) are well-suited for reproducing and documenting surgical procedures.
Patent PT-1052250-E (PT)
Inventor: GETMAN DANIEL P
IPC: C07D263/56
Filed: 1996-03-07
Abstract: Selected sulfonylalkanoylamino hydroxyethylamine sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease. The present invention relates to such retroviral protease inhibitors and, more particularly, relates to selected novel compounds, composition and method for inhibiting retroviral proteases, such as human immunodeficiency virus (HIV) protease, prophylactically preventing retroviral infection or the spread of a retrovirus, and treatment of a retroviral infection.
Patent PT-1198609-E (PT)
Inventor: LEYENDECKER ANTONIUS
IPC: B24C1/10
Filed: 2000-05-29
Abstract: The invention relates to a process for producing a hard-material-coated component, comprising the following steps: application of a layer of hard material to the component in a PVD coating unit; and structural further processing of the outer surface of the layer of hard material, and to a component produced using the process. Particularly in the case of thick coatings or coatings with a columnar structure, such processes have a problem producing a sufficiently smooth surface on the coating. The problem is solved by the fact that for the structural further processing, the surface of the layer is blasted in a blasting device in order to improve this surface, an inorganic blasting agent with a grain size in the range from 1 mum to 100 mum and a sharp-edged grain shape being used.
Patent PT-1235754-E (PT)
Inventor: CRUDELI RAOUL CANDIDI TOMMASI
IPC: E02B7/00
Filed: 2000-08-23
Abstract: Apparatus for checking and, if required, for recovering water that has been cleaned of road deposits, under both normal and emergency conditions, with means for conveying the liquids (CO, 3, 6), a storage/sedimentation system (4) and, if required, floating separators (5), characterised by the fact that, before the conveyor channel (CO) collector system (2), there is a shut-off means made up of traps (1) with disappearing bladders (11), activated by a sensor that detects polluted or unacceptable material (7), to shut off its flow.
Patent PT-1237499-E (PT)
Title: Bandage for wound or incision closure
Inventor: LEBNER MICHAEL
IPC: A61B17/08
Filed: 2000-11-28
Abstract: Disclosed is a bandage for closing a wound or incision, and methods for the use of same. The bandage comprises a first flat flexible component having adhesive on a lower surface and a plurality of first elongated connectors extending from one edge thereof in a first direction. The bandage further comprises a second flat flexible component having adhesive on a lower surface and one or more second elongated connectors extending from one edge thereof in a second direction generally opposite to the first direction. Pulling elements are joined to the first and second elongated connectors. Means are provided for attaching the first elongated connectors to the second flat flexible component and the second elongated connectors to the first flat flexible component.
Patent PT-1252163-E (PT)
Inventor: LAUFER STEFAN
IPC: C07D471/04
Filed: 2001-01-31
Abstract: 4-Pyridyl- or 4-pyrimidinyl-substituted fused bicyclic pyrrole derivatives (I) are new. Fused pyrrole derivatives of formula (I) and their optical isomers, salts and readily physiologically hydrolyzable esters are new: [Image] one of R 1-R 34-pyridyl, 2,4-pyrimidyl (sic) or 3-amino-2,4-pyrimidyl (sic) (optionally substituted by 1 or 2 1-4C alkyl or halo); and a second of R 1-R 3phenyl or thienyl (both optionally substituted by 1 or 2 1-4C alkyl or halo); and the third of R 1-R 3H, COOH, (1-6C) alkoxycarbonyl, CH 2OH or 1-6C alkyl; R 4, R 5H or 1-6C alkyl; X : CH 2, S or O; and n : 1 or 2. (N.B. Formulae given in the disclosure suggest that '2,4-pyrimidyl' should be 4-pyrimidyl and that '3-amino-2,4-pyrimidyl' should be 2-amino-4-pyrimidyl). - ACTIVITY : Immunomodulator; immunosuppressive; cytostatic; neuroprotective; antiarthritic; antiinflammatory; antibacterial; respiratory. - MECHANISM OF ACTION : Cytokine release inhibitor; 5-lipoxygenase inhibitor; cyclooxygenase-1 inhibitor; cyclooxygenase-2 inhibitor. In particular (I) inhibit the release of inflammatory mediators such as tumor necrosis factor-alpha (TNFalpha ), interleukin-1beta (IL-1beta ), leukotriene B4 (LTB4) and prostaglandin E2 (PGE2). (3-(4-Fluorophenyl)-2-(4-pyridyl)-6,7-dihydro-5H-pyrrolizin-1-yl)-met hanol (Ia) had IC 50 values of 4.0 MicroM and 5.0 MicroM respectively for inhibition of Escherichia coli 026:B6 lipopolysaccharide-induced release of TNFalpha and IL-1beta in human peripheral blood mononuclear cells.
Patent PT-1284920-E (PT)
Title: Drinks dispensing device with a removable handle
Inventor: KLAAUW GUIDO PETRUS JOHANNES VAN DER
IPC: B67D1/00
Filed: 2001-05-31
Abstract: Drink dispenser assembly (25,27) comprising a dispenser device (25) with a cooling chamber (26), a hollow column (30) supported on the cooling chamber and a dispensing head (29) on the column for accommodating a flexible dispensing line (28), and a container (27) containing carbonated drink, connected during use to the dispensing line (28) which has a coupling element (32) at an outlet end for connection to the dispensing head (29), wherein the cooling chamber is provided with a door for introducing the container into the cooling chamber and with an outlet opening in a top wall communicating with the hollow column (30), the cooling chamber comprising a curved guide member (35) with a substantially vertically orientated downstream end extending towards the outlet opening and with an entry end, at an angle to the downstream end. <IMAGE>
Patent PT-1292290-E (PT)
Inventor: ROSA GERONI MARIA CRISTINA
IPC: A61K45/06
Filed: 2001-06-20
Abstract: The present invention provides the combined use of acryloyl distamycin derivatives, in particular alpha-bromo- and alpha-chloro-acryloyl distamycin derivatives of formula (I), as set forth in the specification, and an antineoplastic topoisomerase I or II inhibitor, in the treatment of tumors. Also provided is the use of the said combinations in the treatment or prevention of metastasis or in the treatment of tumors by inhibition of angiogenesis.
Patent PT-1233408-E (PT)
Inventor: DEJACO ANDREW P
IPC: G10L19/24
Filed: 1995-08-01
Abstract: A method of adding hangover frames to a plurality of frames encoded by a vocoder, the method comprising: detecting that a predefined number of successive frames has been encoded at a first rate; determining that a next successive frame should be encoded at a second rate that is less than the first rate; and selecting a number of successive hangover frames beginning with the next successive frame to encode at the first rate, the numbering dependent upon an estimate of a background noise level.
Patent PT-1373723-E (PT)
Title: Method for monitoring a wind energy plant
Inventor: WOBBEN ALOYS
IPC: F03D11/00
Filed: 2002-02-14
Abstract: In one aspect, the present invention relates to a system for monitoring wind turbines, wherein image and acoustic monitoring, in particular, is performed. In order to further improve, for example, the maintenance, safety and efficiency of a wind turbine, it is desirable to monitor additional parameters of the wind turbine. A wind turbine is provided, wherein acoustic and optical sensors are employed to monitor the operation of the wind turbine. In one embodiment, the optical sensor images a particular location in the nacelle housing when the acoustic sensor detects a sound emanating from that location in the nacelle housing. A method for monitoring a wind turbine is described wherein when a deviation between the operating acoustic spectrum and the reference acoustic spectrum exceeds the threshold, the component that generated the operating acoustic spectrum is imaged.
Patent PT-1392697-E (PT)
Inventor: STACK GARY PAUL
IPC: A61P25/00
Filed: 2002-03-12
Abstract: Compounds of the formula (I): are useful for the treatment of depression (including but not limited to major depressive disorder, childhood depression and dysthymia), anxiety, panic disorder, post-traumatic stress disorder, premenstrual dysphoric disorder (also known as premenstrual syndrome), attention deficit disorder (with and without hyperactivity), obsessive compulsive disorder, social anxiety disorder, generalized anxiety disorder, obesity, eating disorders such as anorexia nervosa, bulimia nervosa, vasomotor flushing, cocaine and alcohol addition, sexual dysfunction and related illnesses.
Patent PT-1399144-E (PT)
Inventor: PLATA-SALAMAN CARLOS R
IPC: A61P25/20
Filed: 2002-02-21
Abstract: This invention is directed to a method for preventing or treating anxiety disorders comprising administering to a subject in need thereof a therapeutically effective amount of a compound selected from the group consisting of Formula (I) and Formula (II): wherein phenyl is substituted at X with one to five halogen atoms selected from the group consisting of fluorine, chlorine, bromine and iodine; and, R1, R2, R3, R4, R5 and R6 are independently selected from the group consisting of hydrogen and C1-C4 alkyl; wherein C1-C4 alkyl is optionally substituted with phenyl (wherein phenyl is optionally substituted with substituents independently selected from the group consisting of halogen, C1-C4 alkyl, C1-C4 alkoxy, amino, nitro and cyano).
Patent PT-1348429-E (PT)
Title: Melt-extruded orally administrable opioid formulations
Inventor: CHASIN MARK
IPC: A61K9/26
Filed: 1995-11-03
Abstract: A sustained release oral analgesic dosage form, comprising a combination of a pharmaceutical extrudate in the form of multiparticulates including 5 mg to 400 mg oxycodone or a salt thereof dispersed in a matrix and a pharmaceutical extrudate in the form of multiparticulates including a mu-antagonist dispersed in a matrix.
Patent PT-1514325-E (PT)
Title: Accumulateur au lithium
Inventor: SANNIER LUCAS
IPC: H01M50/457
Filed: 2003-06-16
Abstract: Lithium accumulator comprising positive and negative electrodes and a liquid electrolyte containing a lithium salt includes a separator (S1) comprising a polymer gelled by the electrolyte and a separator (S2) comprising a polymer plasticized by the electrolyte, S2 being in contact with S1.  An Independent claim is also included for production of such an accumulator by placing a first layer of gellable polymer on the negative electrode, placing a second layer of plasticizable polymer on the first layer, optionally placing a third layer of gellable polymer on the second layer, placing the positive electrode on the resulting separator, and impregnating the separator with the liquid electrolyte.
Patent PT-1568581-E (PT)
Title: Cleaning trolley
Inventor: SALMON DIRK
IPC: A61G12/00
Filed: 2004-02-24
Abstract: The cleaning trolley has a base (1), at least three wheels (2) on the sides or under the base, a structure (3) installed above the base to accommodate cleaning utensils, and a handle (4). At least one electric motor is installed on the underside of the base and is in functional communication with a transmission acting on at least one of the wheels. A battery arrangement is fitted on the underside of the base. A control unit is connected to the electric motor and battery arrangement and has an operating device (11) in the region of the handle.
Patent PT-1721547-E (PT)
Title: Lateral guide for a pull-out element of a vertical drawer
Inventor: FULTERER MANFRED
IPC: A47B88/04
Filed: 2006-03-31
Abstract: The guide has a middle rail (11) movably guided opposite to a body rail and a pull-out rail (13) guided opposite to the middle rail. A vertical bar (23) of the pull-out rail is projected into a part of a longitudinal extension of the pull-out rail between side pieces (20, 21) of the middle rail. An attachment roller (37) is rotatably supported for synchronously guiding the middle rail during pulling-out of a tall cupboard part from a tall cupboard body at one of the side pieces. The roller is rolled-up in a path at one of the side pieces and in another path at the bar. An independent claim is also included for a tall cupboard pull-out comprising a side guide.
Patent PT-1741446-E (PT)
Title: Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents
Inventor: VILLHAUER EDWIN BERNARD
IPC: A61P3/00
Filed: 2001-01-19
Abstract: The invention relates to a combination which comprises a DPP-IV inhibitor (preferably NVP LAF237 (vildagliptin) or NVP-DPP728) and at least one further antidiabetic compound, preferably selected from the group consisting of insulin signalling pathway modulators, like inhibitors of protein tyrosine phosphatases (PTPases), non-small molecule mimetic compounds and inhibitors of glutamine-fructose-6-phopshate amidotransferase (GFAT), compounds influencing a dysregulated hepatic glucose production, like inhibitors of glucose-6-phosphatase (G6Pase), inhibitors of fructose-1,6-bisphosphatase (F-1,6-BPase), inhibitors of glycogen phosphorylase (GP), glucagon receptor antagonists and inhibitors of phosphoenolpyruvate carboxykinase (PEPCK), pyruvate dehydrogenase kinase (PDHK) inhibitors, insulin sensitivity enhancers, insulin secretion enhancers, ±-glucosidase inhibitors, inhibitors of gastric emptying, insulin, and ± 2 -adrenergic antagonists, for simultaneous, separate or sequential use in the prevention, delay of progression or treatment of conditions such as type 2 diabetes mellitus, impaired glucose tolerance (IGT), impaired fasting plasma glucose, metabolic acidosis, ketosis, arthritis, obesity and osteoporosis.
Patent PT-1925192-E (PT)
Title: Laminated substrate for mounting electronic parts
Inventor: DITZEL ECKHARD
IPC: H01L21/48
Filed: 2006-09-08
Abstract: A method is provided for producing a laminated substrate for mounting semiconductor chips. At least respective metal and plastic structure films having respective different recurrent contours are laminated together in such a way that a material strip is obtained. The lamination is followed by perforations or cuttings, and the method includes at least one of the following steps: A. the films are structured in such a way that superposition thereof makes it possible to obtain the areas which are devoid of overlap through the total width thereof; B. the films are not laminated through the total width of the laminate in partly recurrent areas; and C. recurrent segments of the recurrent contours are bent out of the surface of the laminated strip starting from the laminate.
Patent PT-1991875-E (PT)
Title: Test for the detection of pathological prions
Inventor: REINHARD LATZA DR
IPC: G01N33/68
Filed: 2007-03-03
Abstract: The am of the invention is to create a method for detecting pathological prions which is highly sensitive, can be carried out quickly and at a low cost, and allows prions to be detected at an early stage of a disease. Said aim is achieved by the fact that immobilized capture antibodies bind the pathological and non-pathological form of the prion protein contained in a sample whereupon the bound non-pathological form is specifically divided by means of plasmin. The undivided, pathological form of the prion protein, which is bound by the immobilized capture antibodies, can then be easily detected with the aid of detection antibodies. The inventive method is used for detecting pathological prions.
Patent PT-1996571-E (PT)
Title: Tetracyclic steroid derivatives useful as progesterone receptor modulators
Inventor: SUI ZHIHUA
IPC: A61K31/335
Filed: 2007-02-16
Abstract: The present invention is directed to tetracyclic steroid derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by a progesterone or glucocorticoid receptor.
Patent PT-1958935-E (PT)
Title: Process for the production of terfenadine and carebastine derivatives with microorganisms
Inventor: ZIRBES ERIC L
IPC: C07D211/46
Filed: 2001-11-06
Abstract: The production of a product compound having a structure according to Formulae IA and/or IB wherein n, R 1 , R 2 , A, B, and D are defined as herein; 
R 3  is -COOH or -COOR4; R 4  is an alkyl or aryl moiety; This process involves incubating a starting compound having a structure according to Formulae IIA and/or IIB wherein R 3  is -CH 3  and R 1 , R 2 , A, B, and D are defined above, in the presence of a microorganism. The microorganism can be from the genus  Bacillus, Pseudomonas. Gliocladium, Botrytis, Cyathus, Rhizopus, Pycniodosphora, Helicostylum, Aspergillus, Mucor, Gelasinospora, Rhodotorula, Candida, Mycobacterium  or  Penicillium,  or it can be  Cunninghamella bainieri, Absidia spinosa var. biappendiculata, Ascoidia, Enterococcus faecium, Fusidium coccineum, Hansends cadaver yeast, Lentinus lepidius, Lophotrichus martinii, Polyporus anceps. Spicaria violacea, Streptomyces catenulae, Streptomyces cavourensis, Streptomyces griseus, Streptomyces rimosus  or  Trichophyton gallinae.
Patent PT-2009206-E (PT)
Title: Fixing element for fixing a hinge to the jamb of a door or window frame or the like
Inventor: PARYS REMI EMIEL VAN
IPC: E05D5/02
Filed: 2008-06-12
Abstract: Fixing element (3) for fixing a hinge (2) to the jamb (1) of a door or window frame or the like, characterised in that the fixing element (3) is made as a pen (14) to which the hinge (2) is fixed or can be fixed, and which is provided crosswise through a passage (12) in the jamb (1) and which is locked in relation to this jamb (1) by means of a locking screw (19) which is screwed down through a continuous threaded hole (16) which extends through the pen (14) at an angle as of a crosscut end (17) of the pen (14) in relation to the axis of the pen, up to the outer wall (18) of the pen (14), whereby the locking screw (19) for fixing the hinge (2) is screwed down until its free end (20) makes contact with the jamb (1) concerned.
Patent PT-2203243-E (PT)
Title: Advanced control method for a membrane filtration unit, and device for implementing the method
Inventor: LANGLAIS CHRYSTELLE
IPC: B01D61/18
Filed: 2008-10-14
Abstract: Advanced control method for a membrane filtration unit, applied to the treatment of an effluent, employing microcoagulation on a membrane, which consists in injecting, upstream of the membrane, a dose of coagulation reactant(s) 30 to 80 times below the dose (X) making the zeta potential of the effluent zero, in which method: quantities defining the quality of the effluent to be treated and quantities defining the state of membrane clogging are measured as input variables; the operating point of the microcoagulation process is located on the basis of the results of the above measurements; thresholds for the input variables are determined, the microcoagulation having to be initiated when said thresholds are violated; and the coagulation reactant(s) is(are) injected depending on the results of the measurements and on the comparison of the input variables with the respective thresholds.
Patent PT-2182203-E (PT)
Title: Wind turbine rotor blade with an extension
Inventor: WILKENS BODO
IPC: F03D1/06
Filed: 2009-11-03
Abstract: The blade (2) has a blade tip extension (6) including glass fiber reinforced upper and lower shelves, which are connected with each other and glued with an end region of the blade. A rib is arranged between the half shelves in a region of a rotor blade tip (4) perpendicular to a rotor blade longitudinal axis (z). The rib includes a central section adapted to a shape of the blade tip for receiving the blade tip. Reinforcing bars extend from the rib in a direction of a blade tip extension tip (8) and are arranged parallel to each other.
Patent PT-626998-E (PT)
Inventor: DOUGHERTY WILLIAM G
IPC: C12N15/83
Filed: 1993-02-18
Abstract: A method of suppressing virus gene expression in plants using untranslatable plus sense RNA is disclosed. The method is useful for the production of plants that are resistant to virus infection.
Patent PT-689773-E (PT)
Inventor: ERICKSON JOHN P
IPC: A23L27/60
Filed: 1995-05-30
Abstract: Mayonnaise and dressing products, including reduced-calorie low-fat mayonnaise and reduced-calorie, low-fat, spoonable or pourable dressing compositions, having as a preservative system glucono-delta-lactone and, optionally, acetic acid in sufficient quantity to lower the pH to about 3.5 or less, preferably about 3.3 or less. The compositions have an increased resistance to microbial spoilage and, therefore, extended shelf life compared with currently marketed products, yet do not have the sharp acidic "bite" common to currently available products.
Patent PT-766566-E (PT)
Inventor: ABRAHMSEN LARS
IPC: A61K47/48
Filed: 1995-06-07
Abstract: A method for the treatment of a disease in a mammal by administering a therapeutically effective amount of a conjugate comprising a biospecific affinity counterpart and a peptide, wherein the peptide contains an amino acid sequence that is derived from staphylococcal enterotoxin A, binds to a Vbeta of a T cell receptor, and has a D227A mutation so that the peptide has a modified ability to bind to MHC class II antigens.
Patent PT-779408-E (PT)
Inventor: JORG RAUSCHENBERGER DIPL ING
IPC: F16B17/00
Filed: 1996-12-11
Abstract: The connection has a region of overlap between the rail and an arm (2) of the hinge, in which the connection lies. Positive and/or frictional connections are arranged in the corner regions (5,6) of the arm and rail profiles, and/or in the sides (2.2,3.2) of the profiles which lie roughly parallel to the hinge axis (AG). The connections may be formed by reshaping, in which the material of the side rail is introduced into recesses or depressions in the arm of the hinge.
Patent PT-857018-E (PT)
Inventor: LEE KUO-HSIUNG
IPC: A61K31/21
Filed: 1996-06-05
Abstract: Betulinic acid derivs. of formula (I) and (II) are new. In (I) the dotted line is a double bond; in (II) the dotted line is a single bond; R = opt. substd. 2-20C mono- or di-carboxyacyl; and R' = H, opt. substd. 2-20C alkyl, or aryl. Also claimed is a compsn. contg. (I) or (II), or their esters, salts, ethers, sulphates or glucuronides, and an anti-viral agent or an immunostimulating agent.